Inventor · disambiguated record
Ian Charles Parrag
Also filed as: PARRAG IAN · PARRAG IAN CHARLES
9 granted patents·11 pending applications·16 citations·filing 2019–2024
84Inventor score
Files withRIPPLE THERAPEUTICS CORP20
Top patents by PatentIndex Score
20 records- 0193US10588862B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 17, 2020·5 cites·50 claims
- 0292US10959954B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 30, 2021·3 cites·19 claims
- 0392US10945958B2Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·19 claims
- 0492US10632075B2Glass formulations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Apr 28, 2020·4 cites·29 claims
- 0585US2025049719A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 0684US11279729B2Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Granted Mar 22, 2022·1 cites·11 claims
- 0781US2023225975A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 0875US11612567B2Ocular inserts comprising a covalently linked steroid dimerRIPPLE THERAPEUTICS CORP·Filed 2019·Granted Mar 28, 2023·0 cites·15 claims
- 0975US2025065053A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1072US2021205222A1Dexamethasone prodrug compositions and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1168US2023113525A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1263US2025074935A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 1361US11464914B2Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 1461US2022387213A1Intravitreal injectorRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 1561US2025057962A1Processable compositions and use for the sameRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 1660US2022106351A1Heterodimer compositions and methods for the treatment of ocular disordersRIPPLE THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1755US12473326B2Crystalline forms of dexamethasone dimers and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Nov 18, 2025·0 cites·12 claims
- 1850US12509469B2Compositions and methods for the treatment of pain and dependence disordersRIPPLE THERAPEUTICS CORP·Filed 2020·Granted Dec 30, 2025·0 cites·13 claims
- 1949US2022289787A1Dimer combinations and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2048US2022288277A1Surface coatings and implantable devices comprising dimeric steroid prodrugs, and uses thereofRIPPLE THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Charles Parrag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →